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Proteins of the MRTF family play a key role in regulated
gene expression downstream of Rho family GTPases.
MAL/MKL1/MRTF-A is a transcriptional coactivator of
serum response factor (SRF) and is bound and inhibited
by G-actin in the non-induced state. In acute megakaryo-
cytic leukaemia in infants, a recurrent translocation
t(1;22) results in the OTT-MAL/RBM15-MKL1 fusion
oncoprotein. How it contributes to the malignancy is
unknown. We tested by biochemical analysis whether
OTT-MAL is functionally deregulated. We showed that
OTT-MAL is a constitutive activator of SRF and target gene
expression. This requires the SRF binding motif and the
MAL-derived transactivation domain. OTT-MAL localises
to the nucleus and is not regulated by upstream signalling.
OTT-MAL deregulation reflects its independence from
control by G-actin, which fails to interact with OTT-MAL
in co-immunoprecipitation experiments. OTT-MAL also
caused a delayed induction of the MAL-independent, TCF-
dependent target genes c-fos and egr-1, and the MAPK/Erk
pathway. In addition, RBPJ/CBF-1 regulated gene expres-
sion was activated by OTT-MAL but not by MAL. Our data
suggest that the deregulated activation of MAL-dependent
and independent promoters results in tissue-specific func-
tions of OTT-MAL.
When tested in heterologous tissue culture systems, how-
ever, we observed strong anti-proliferative effects of OTT-
MAL. Similarly, overexpression of MAL exhibited antipro-
liferative and pro-apoptotic effects requiring transcription
through SRF. To gain insight into the molecular mecha-
nisms involved, we performed gene expression analysis.
By using a combination of actin binding drugs, which spe-
cifically interfere with the actin-MAL complex, we identi-
fied on a genome wide basis 210 genes primarily
regulated by G-actin. We found many known MAL-
dependent SRF target genes, as well as novel directly regu-
lated genes. Several putative antiproliferative target genes
were newly identified. We showed that a group of MAL
regulated genes negatively interferes with the EGFR-MAPK
pathway, thereby reducing proliferative signalling. Our
results show the existence of negatively acting transcrip-
tional networks between pro- and antiproliferative signal-
ling pathways towards subsets of SRF target genes.
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